Impact of Treatment With ALVEOGYL in Patients With Post-extraction Dry Socket

NCT ID: NCT05536115

Last Updated: 2023-11-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-12-13

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Alveogyl (Septodont, Saint-Maur-des-Fossés - France) is a Medical Device used as dressing in case of dry socket.

ALVE study is a clinical investigation measuring Alveogyl performance and safety in patients with post-extraction dry socket.

The study takes place in India and in France where Alveogyl is already marketed, since 2010 in France and since 2014 in India .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dry Socket

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study population

Study patients are patients with post-extraction dry socket.

Alveogyl

Intervention Type DEVICE

The patients will be treated by Alveogyl. Global treatment protocol (curettage, cleaning, local anaesthesia etc.) of the dry socket is at the discretion of the Investigator.

Alveogyl is used as an alveolar dressing. Placement of Alveogyl (about 0.2 g of paste) into the dental socket is done according to its instruction for use by a dental professional only.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Alveogyl

The patients will be treated by Alveogyl. Global treatment protocol (curettage, cleaning, local anaesthesia etc.) of the dry socket is at the discretion of the Investigator.

Alveogyl is used as an alveolar dressing. Placement of Alveogyl (about 0.2 g of paste) into the dental socket is done according to its instruction for use by a dental professional only.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female patient, adult or child
* Positive diagnosis of dry socket occurring after the extraction of a permanent tooth (mature or immature)
* Signed informed consent
* In France only :Patient affiliated to a Health Insurance Scheme ("sécurité sociale")

Exclusion Criteria

* Spreading infection in the alveolar socket
* Placement of Alveogyl done immediately after tooth extraction
* Multiple post-extraction dry sockets
* Patient treated with cervico-facial radiotherapy
* Immunodeficiency related to any diseases or current treatments
* Psychiatric patient or patient unable to assess his/her pain via the study Pain VAS
* Patient with history of hypersensitivity to one of the components
* Patient on post extraction of deciduous teeth
* Participation in another clinical investigation
Minimum Eligible Age

5 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

SMO Clinical Research

UNKNOWN

Sponsor Role collaborator

QualityStat

UNKNOWN

Sponsor Role collaborator

Septodont

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Géraldine Lescaille, DDS, PhD

Role: STUDY_DIRECTOR

Odontology department - Pitié-Salpêtrière Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Henri-Mondor (AP-HP)

Créteil, , France

Site Status RECRUITING

Odontology Department - Pitié-Salpêtrière Hospital

Paris, , France

Site Status RECRUITING

Mallige Hospital

Bangalore, Karnataka, India

Site Status COMPLETED

Smile Dental Care

Bangalore, Karnataka, India

Site Status COMPLETED

Perfect Dental Studio

Bangalore, Karnataka, India

Site Status COMPLETED

Cavalier Hospital

Bangalore, Karnataka, India

Site Status COMPLETED

Smile Dental Clinic

Bangalore, Karnataka, India

Site Status COMPLETED

The Dental Avenues

Bangalore, Karnataka, India

Site Status COMPLETED

Sri Dental Multispeciality Dental Hospital

Hyderabad, , India

Site Status COMPLETED

Vrisa Dental

Hyderabad, , India

Site Status COMPLETED

Eledent International Digital Dentistry

Hyderabad, , India

Site Status COMPLETED

Vardhaman Dental Care

Mumbai, , India

Site Status COMPLETED

Mayur Dental Clinic

Mumbai, , India

Site Status COMPLETED

Smile Gallery Dental Care Center

Pune, , India

Site Status COMPLETED

Dr. Salke Dental & Implant Centre

Pune, , India

Site Status COMPLETED

Sri Siddhartha Dental College

Tumakuru, , India

Site Status COMPLETED

Countries

Review the countries where the study has at least one active or historical site.

France India

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Farid BENABDALLAH, MD

Role: CONTACT

+33 (0)7 85 66 21 79

Raphaël HADDAD

Role: CONTACT

+33 (0)6 76 75 04 57

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Francesca MANGIONE, MD, PhD

Role: primary

Géraldine Lescaille, DDS, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-A00208-35

Identifier Type: REGISTRY

Identifier Source: secondary_id

CI/MD/2022/66273

Identifier Type: REGISTRY

Identifier Source: secondary_id

ALVE 2022-01

Identifier Type: -

Identifier Source: org_study_id